before describing the features of the present invention , it is appropriate to briefly describe the construction of one type of known cochlear implant system with reference to fig1 . known cochlear implants typically consist of two main components , an external component including a speech processor 9 , and an internal component including an implanted receiver and stimulator unit 2 . the external component includes a microphone 7 . the speech processor 9 is , in this illustration , constructed and arranged so that it can fit behind the outer ear 1 . alternative versions may be worn on the body . attached to the speech processor 9 is a transmitter coil 4 which transmits electrical signals to the implanted unit 2 via a radio frequency ( rf ) link . the implanted component includes a receiver coil 3 for receiving power and data from the transmitter coil 4 . a cable 41 extends from the implanted receiver and stimulator unit 2 to the cochlea 30 and terminates in an electrode array 20 . the signals thus received are applied by the array 20 to the basilar membrane 8 and the nerve cells within the cochlea 30 thereby stimulating an auditory nerve 5 . the operation of such a device is described , for example , in u . s . pat . no . 4 , 532 , 930 . one embodiment of a cochlear implant electrode assembly according to the present invention is depicted generally as 10 in fig2 and 3 . the depicted electrode assembly 10 has an electrical lead extending back to a stimulator / receiver housing , such as the stimulator unit 2 depicted in fig1 . in considering this invention , it is to be understood that each electrode 12 may have one or more wires ( not depicted ) electrically connected thereto and extending from each respective electrode 19 back through the lead to the stimulator / receiver . the assembly 10 comprises an elongate electrode carrier member 11 having a plurality of electrodes 12 mounted thereon . for the purposes of clarity , the electrodes 12 depicted in fig1 are not necessarily shown to scale . a larger number of electrodes than that depicted in fig2 can also be envisaged . the electrodes 12 are not depicted in fig3 for reasons of clarity . the depicted elongate member 11 is preformed from a resiliently flexible silicone with memory and is preformed to a curved configuration suitable for insertion in the scala tympani 31 of a human cochlea 30 . while an assembly that normally adopts a curved configuration when in a relaxed condition is depicted in the drawings , it will be appreciated that the present invention also could be utilised with respect to assemblies that are normally straight when in a relaxed condition . the elongate member 11 has a first end 13 that is firstly inserted into the cochlea 30 upon insertion of the assembly 10 . as depicted in fig2 , there is disposed within a lumen 14 , prior to insertion of the assembly 10 into the cochlea 30 , a substantially straight platinum stylet 15 . in the depicted embodiment , the stylet 15 has a stiffness that is sufficient to retain the silicone elongate member 11 in a straight configuration . the stylet could be constructed so as to have a stiffness that was insufficient alone to retain the elongate member 11 in a straight configuration . in this case , the elongate member could have a stiffening sheath 18 that at lest partially envelops the elongate member 11 . the stiffening sheath 18 could be formed of a bioresorbable material which prior to implantation assists the platinum stylet in maintaining the elongate member 11 in the straight configuration . while a platinum stylet is depicted , a bioresorbable stylet - like member formed from a bioresorbable material , such as polyacrylic acid ( paa ), that is also impregnated with a bio - active substance and which is adapted to dissolve or soften on exposure to cochlear fluids , could be utilised with appropriate modification to the elongate carrier member 11 . a stiffening polymer stylet could also be utilised which could be impregnated with a bio - active substance . such a stylet would soften quickly , but not dissolve quickly , with its very slow dissolution rate allowing the drug to effectively elute to the body . equally , whilst a substantially cylindrical lumen is depicted , the lumen 14 could indeed be any shape necessary to perform the function . again , the paa stylet - like member in this invention can have a stiffness that is either sufficient or insufficient to retain the silicone elongate member 11 in a straight configuration as depicted in fig2 . it will be appreciated that a bioresorbable stylet - like member could be formed from other suitable bioresorbable materials . a stylet - like member made from a shape memory or heat sensitive material could also be utilised instead of stylet 15 . in the depicted embodiment , the elongate member 11 is adapted to also act as a system for delivery of one or more pharmaceutical or bioactive substances to the cochlea 30 . in the depicted embodiment , this system is provided by an additional lumen 21 that acts as a reservoir for a fluid 23 constituting or including the one or more pharmaceutical or bioactive substances . the lumen 21 is pre - filled with the pharmaceutical or bioactive substances during manufacture and then sealed by the plug closure 22 . provided at the first end 13 of the member 11 is a fluid egress means comprising a valve 24 in the form of a slit formed in the structure of the elongate member 11 . other embodiments with more than one slit 24 can be envisaged . the slit 24 is adapted to allow fluid 23 within the lumen 21 to exit the lumen 21 but prevents fluid flow from external the member 11 back into the lumen 21 . to prevent flow of fluid through the slit 24 prior to implantation , the slit is covered with a layer 25 of bioresorbable paa . other suitable bioresorbable materials could be envisaged and the material could also be impregnated with the pharmaceutical substance . while only depicted as covering the slit 24 , the layer 25 could coat a greater portion or the entire surface of the elongate member 11 . on insertion of the elongate member 11 into the scala tympani 31 , the cochlear fluid commences to soften and dissolve the layer 25 of paa . in addition to lubricating the first end 13 , the dissolution of the layer 25 allows the fluid 23 to commence to flow from the lumen 21 into the scala tympani 31 . it is also possible that the pharmaceutical or bioactive substance 23 could be released from the lumen 21 by way of a mechanical means . such a means may include pushing the stylet 15 through the slit 24 at the end of the assembly 10 to break the seal just prior to insertion . as shown in fig6 a and 6b , another method of releasing the pharmaceutical substance would be to include a suture 26 down the lumen 21 and through the seal 25 . the suture 26 could then be pulled in an action similar to a “ rip - cord ” to open the end of the assembly 10 . in the embodiments shown in fig4 , lumen 21 is in fluid communication with an additional reservoir 45 for fluid 23 . additional reservoir 45 can be placed under the skin of the implantee and be fillable by a needle and syringe assembly when required . a pump 47 , such as an osmotic pump , can be used to transfer fluid from additional reservoir 45 to lumen 21 . while depicted with a lumen 21 , it can also be envisaged that the elongate member 11 could be impregnated with a pharmaceutical agent or other bioactive substance prior to implantation . the pharmaceutical agent or bioactive substance would then be free to leach from the elongate member 11 following insertion . in this embodiment , it can be envisaged that a layer of bioresorbable paa material may coat the entire impregnated portion of the elongate member 11 so ensuring that the pharmaceutical agent or bioactive substance does not leach from the elongate member 11 prior to implantation . while the elongate member 11 is manufactured with a preformed curved configuration , the depicted assembly 10 is typically delivered to a surgeon in a sterile package with the stylet 15 and pharmaceutical fluid 23 in place ( as depicted in fig2 ). on removal from the package and insertion into the scala tympani 31 of the cochlea 30 , the cochlear fluids commence to dissolve and soften the layer 25 . as the elongate member 11 is inserted into the scala tympani 31 of the cochlea 30 , the surgeon can commence to withdraw the stylet 15 from the lumen 14 through opening 17 . on withdrawal of the stylet 15 , the elongate member 11 is free to adopt the spiral configuration depicted in fig3 with the electrodes 12 facing the modiola within the cochlea 30 so that they are positioned as close as possible to the spiral ganglia thereof . the provision of a system for delivering a pharmaceutical substance that promotes healing and / or more efficient neural stimulation while preventing the formation of substantial scar tissue in the cochlea , enhances the likelihood of successful long - term placement of the assembly 10 in the cochlea and subsequent successful use of the cochlear implant by the implantee . while the preferred embodiment of the invention has been described in conjunction with a cochlear implant , it is to be understood that the present invention has wider application to other implantable electrodes , such as electrodes used with pacemakers . it will be appreciated by persons skilled in the art that numerous variations and / or modifications may be made to the invention as shown in the specific embodiments without departing from the spirit or scope of the invention as broadly described . the present embodiments are , therefore , to be considered in all respects as illustrative and not restrictive . all documents , patents , journal articles and other materials cited in the present application are hereby incorporated by reference . it is to be understood that the detailed description and specific examples , while indicating embodiments of the present invention , are given by way of illustration and not limitation . many changes and modifications within the scope of the present invention may be made without departing from the spirit thereof , and the invention includes all such modifications .
an implantable tissue - stimulating device , such as a cochlear implant , having a resiliently flexible elongate member having a plurality of electrodes positioned thereon . the elongate member provides a means of delivering at least one bio - active substance to the implantee following implantation of the elongate member . the delivery means can comprise a lumen 21 containing the bio - active substance in a liquid form . the bio - active substance can comprise a steroid or can perform a function of reducing the resting neuron potential of neurons within the cochlea .